跳至主要内容
临床试验/TCTR20210924001
TCTR20210924001终止3 期

Customized Citrate Anticoagulation vs. No Anticoagulant in Continuous Venovenous Hemofiltration in Critically ill patients with Acute Kidney Injury : a prospective randomized controlled trial

Faculty of Medicine Siriraj Hospital , Mahidol University ,Thailand0 个研究点目标入组 78 人开始时间: 2021年9月24日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • 1.Age > 18 yours
  • 2.Critically ill patients with acute kidney injury who admitted to ICU
  • 3.Fullfils at least ONE of the following for initiating Continuous renal replacement therapy (CRRT)
  • 3.1 Refractory volume overload
  • 3.2 Refractory hyperkalemia
  • 3.3 Uremic symptom
  • 3.4 Refractory metabolic acidosis

排除标准

  • 1.Patient who need systemic anticoagulation
  • 2.Chronic renal replacement therapy
  • 3.Pregnancy , Breast feeding
  • 4.Post hepatic resection , severe acute liver failure , waiting list for liver transplantation
  • 5.Serum Na > 160 mEq/L or Serum HCO3 > 40 mEq/L or pH >7.5 before renal replacement therapy
  • 6.Active bleeding
  • 7.Persistent symptomatic hypocalcemia or total calcium / ionized calcium ratio >2.5
  • 8.Refuse to participate
  • 9.Citrate allergy

研究者

发起方
Faculty of Medicine Siriraj Hospital , Mahidol University ,Thailand

相似试验

Customized Citrate Anticoagulation versus No... | 临床试验